Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism AVPR1A antagonists(Vasopressin V1a receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23Cl2N3O |
InChIKeyKFYLIVATYVZBDM-UHFFFAOYSA-N |
CAS Registry1622294-25-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Preclinical | US | 18 Sep 2014 | |
Depressive Disorder | Preclinical | US | 18 Sep 2014 | |
Stress Disorders, Post-Traumatic | Preclinical | US | 18 Sep 2014 |